$ cat ./records/gates-foundation-announces-additional-50-million-to-covax-and-20--2020.txt
Gates Foundation Announces Additional $50 Million to COVAX and $20 Million to CEPI
[RECORD.TXT] · cat --full
The Bill & Melinda Gates Foundation announced a further $50 million to Gavi's COVAX Advance Market Commitment, bringing cumulative COVAX AMC contributions to $156 million, alongside a concurrent $20 million grant to CEPI to accelerate development of additional COVID-19 vaccine candidates. The pledge also unlocked a matching contribution of approximately £12.5 million from the UK government. COVAX at this point aimed to secure doses for 92 eligible lower-income countries once vaccines received regulatory approval.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation COVID-19 Commitment Reaches $1.75 Billion with Additional $250 Million Pledge
Next →
Gates Foundation Pledges $1.6 Billion to Gavi and $150 Million to COVAX Vaccine Equity Facility
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.